首页> 外文期刊>Microvascular Research: An International Journal >Microvascular permeability of human melanoma xenografts to macromolecules: relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression.
【24h】

Microvascular permeability of human melanoma xenografts to macromolecules: relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression.

机译:人黑素瘤异种移植物对大分子的微血管通透性:与肿瘤体积生长速率,肿瘤血管生成和VEGF表达的关系。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The effective microvascular permeability of human melanoma xenografts to albumin-Evans blue was measured and related to tumor volumetric growth rate, rate of tumor angiogenesis, and expression of vascular endothelial growth factor (VEGF) in an attempt to identify mechanisms regulating the microvascular permeability of tumors to macromolecules. Three melanoma lines (A-07, R-18, and U-25) were included in the study. Effective microvascular permeability was assessed by using the indicator diffusion method. Intradermal and intratumor angiogenesis assays were used to measure the rate of tumor angiogenesis. VEGF expression was studied by ELISA, immunohistochemistry, Western blotting, and measurement of tumor-induced formation of ascitic fluid. The effective microvascular permeabilities of albumin-Evans blue were determined to be (1.5 +/- 0.2) x 10(-6) cm/s (A-07), (1.1 +/- 0.4) x 10(-6) cm/s (R-18), and (0.9 +/- 0.3) x 10(-6) cm/s (U-25). These values are high compared with those measured for other tumor lines and are not significantly different. Correlations between the effective microvascular permeability of albumin-Evans blue and tumor volumetric growth rate, rate of tumor angiogenesis, or VEGF expression were not found. The three last-mentioned parameters differed significantly among the melanoma lines and covered a broad range of values relative to those of other experimental tumors. Our study suggests that the effective microvascular permeability of macromolecules can be high even in slowly growing tumors, poorly angiogenic tumors, and tumors showing low VEGF expression. Copyright 2001 Academic Press.
机译:测量了人黑素瘤异种移植物对白蛋白-伊文思蓝的有效微血管通透性,并与肿瘤体积生长速率,肿瘤血管生成速率和血管内皮生长因子(VEGF)的表达相关,以试图确定调节肿瘤微血管通透性的机制高分子。该研究包括三种黑色素瘤细胞系(A-07,R-18和U-25)。通过使用指示剂扩散法评估有效的微血管通透性。皮内和肿瘤内血管生成测定用于测量肿瘤血管生成的速率。通过ELISA,免疫组织化学,蛋白质印迹和测量肿瘤诱导的腹水形成来研究VEGF的表达。白蛋白-伊文思蓝的有效微血管通透性确定为(1.5 +/- 0.2)x 10(-6)cm / s(A-07),(1.1 +/- 0.4)x 10(-6)cm / s (R-18)和(0.9 +/- 0.3)x 10(-6)cm / s(U-25)。与其他肿瘤细胞系测得的值相比,这些值很高,并且没有显着差异。未发现白蛋白-伊文思蓝的有效微血管通透性与肿瘤体积生长速率,肿瘤血管生成速率或VEGF表达之间的相关性。最后提到的三个参数在黑色素瘤细胞系之间存在显着差异,并且相对于其他实验肿瘤而言,涵盖了广泛的数值范围。我们的研究表明,即使在缓慢生长的肿瘤,血管生成不良的肿瘤和VEGF表达低的肿瘤中,大分子的有效微血管通透性也可能很高。版权所有2001,学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号